Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 02-2025 | 02-2024 | 02-2023 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 0 | 20 | 44 |
| Income taxes - deferred | 0 | -9 | -9 |
| Accounts receivable | 93 | -44 | -104 |
| Accounts payable and accrued liabilities | N/A | 149 | -24 |
| Other Working Capital | 1 | 105 | -128 |
| Other Operating Activity | -309 | -692 | -819 |
| Operating Cash Flow | $-215 | $-470 | $-1,041 |
| Cash Flows From Investing Activities | |||
| Net Acquisitions | N/A | 0 | -171 |
| Purchase Of Investment | N/A | N/A | -50 |
| Other Investing Activity | 0 | -23 | 0 |
| Investing Cash Flow | $0 | $-23 | $-221 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | 0 | -30 | -46 |
| Common Stock Issued | 270 | N/A | 0 |
| Other Financing Activity | 0 | 0 | 1 |
| Financing Cash Flow | $270 | $-30 | $-45 |
| Beginning Cash Position | 29 | 552 | 1,859 |
| End Cash Position | 84 | 29 | 552 |
| Net Cash Flow | $55 | $-524 | $-1,307 |
| Free Cash Flow | |||
| Operating Cash Flow | -215 | -470 | -1,041 |
| Free Cash Flow | -215 | -470 | -1,041 |